Levomilnacipran, but Not Duloxetine, Inhibits Serotonin and Norepinephrine Reuptake Throughout Its Therapeutic Range
The Journal of Clinical Psychiatry · 2025
DOI: 10.4088/jcp.25m15867 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Psychiatry, 2025. Verfasst von Katerina Nikolitch und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Ottawa Institute of Mental Health Research at The Royal, Ottawa, Canada. Hauptthemen laut MEDLINE: Cyclopropanes, Major Depressive Disorder, Milnacipran, Norepinephrine.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Ottawa Institute of Mental Health Research at The Royal, Ottawa, Canada.
- Department of Psychiatry, McGill University, Montreal, Canada.
- Department of Psychiatry, University of Ottawa, Ottawa, Canada.
- Corresponding Author: Pierre Blier, MD, PhD, University of Ottawa Institute of Mental Health Research, 1145 Carling Ave, Ottawa, ON, K1Z 7K4, Canada (pierre.blier@theroyal.ca).
Zitieren
APA
Nikolitch, K., Phillips, J. L., Daniels, S., & Blier, P. (2025). Levomilnacipran, but Not Duloxetine, Inhibits Serotonin and Norepinephrine Reuptake Throughout Its Therapeutic Range. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.25m15867
Vancouver
Nikolitch K, Phillips JL, Daniels S, Blier P. Levomilnacipran, but Not Duloxetine, Inhibits Serotonin and Norepinephrine Reuptake Throughout Its Therapeutic Range. The Journal of Clinical Psychiatry. 2025. doi:10.4088/jcp.25m15867
BibTeX
@article{Nikolitch2025,
author = {Nikolitch, Katerina and Phillips, Jennifer L and Daniels, Stephen and Blier, Pierre},
title = {Levomilnacipran, but Not Duloxetine, Inhibits Serotonin and Norepinephrine Reuptake Throughout Its Therapeutic Range},
journal = {The Journal of Clinical Psychiatry},
year = {2025},
doi = {10.4088/jcp.25m15867}
}
EUVIMED